Cargando...

An exceptional response to olaparib in relapsed and refractory BRCA2 mutated non-small cell lung cancer in hereditary breast–ovarian cancer syndrome

Gardado en:
Detalles Bibliográficos
Publicado en:South Asian J Cancer
Main Authors: Talreja, Vikas T., Noronha, Vanita, Joshi, Amit, Patil, Vijay, Prabhash, Kumar
Formato: Artigo
Idioma:Inglês
Publicado: Wolters Kluwer - Medknow 2020
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6956583/
https://ncbi.nlm.nih.gov/pubmed/31956609
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/sajc.sajc_157_19
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!